Going to ID week? Looking forward to seeing you there!
While you are packing and planning and putting the last minute touches on your posters and powerpoint slides, take a look at some of the excellent work done by our Pitt ID faculty and fellows. Please stop by these presentations in healthcare epidemiology, antimicrobial stewardship, treatment of Gram negative and Gram positive infections, transplant ID, virology, vaccination and mycology. We are proud of this work and all of the contributions from our division members!
Thursday 10/4/18
900 AM: S 206-208
- Symposium: Can You Hear and See Me Now? ID Telehealth
- Rima Abdel-Massih
11:00 AM Room S 158
- Oral Abstract: Evaluation of pneumococcal vaccine effectiveness against invasive pneumococcal disease among U.S. Medicare beneficiaries >=65 years old
- Lee Harrision
12:30 PM Poster Hall
- Poster 64. Microbiota and Associations with Treatment Outcome in Fecal Microbiota Transplantation
- Tatiana Bogdanovich, Nicolas Sluis-Cremer
- Poster 191. Accuracy of Clinical Indications for Use When Ordering Antibiotics for Cystitis in Community Hospitals
- Tina Khadem, Ryan Bariola,
- Poster 205. Reduction of Antibiotic Prescribing within a Veterans Affairs Emergency Department through Peer Comparison
- Brooke Decker, Neil Clancy, Deanna Buehrle, Rameez Phulpoto
- Poster 227. Provider Education Paired with Peer Comparison Demonstrates Sustained Reduction in Overall Antibiotic Prescribing within a Veterans Affairs Primary Care System
- Deanna Buehrle, Brooke Decker, Neil Clancy,
- Poster 247. Sustaining Excellence of Care During A Fluid Shortage: Snapshot of Antibiotic Mitigation Strategies Following Hurricane Maria
- Rachel Marini, Brian Potoski, Bonnie Falcione, Lloyd Clarke, Tina Khadem, Ryan Shields, Neil Clancy, Hong Nguyen, Alex Viehman
- Poster 357. Aspergillus isolates remain largely susceptible to azoles and other antifungals at a large transplant program using azole prophylaxis
- Ellen Driscoll, Neil Clancy, Kevin Squires, Ryan Shields, Hong Nguyen
- 383. An Increased Rate of Candida parapsilosis Infective Endocarditis is Associated with Injection Drug Use
- Alex Viehman, Ryan Shields, Lou Oleksiuk, Neil Clancy, Hong Nguyen
2:00 PM Room N 24
- Controversies in Infection Prevention
- Moderated by Brooke Decker
Friday 10/5/18
10:30 am Room W 2006-2008
- Graham Snyder: Moderator -Symposium “Infection Control and Antimicrobial Stewardship in Dialysis Facilities” on Friday, October 5, 2018 from am
12:30 pm Poster Hall
- Poster 1230. Epidemiology and Risk Factors for Recurrent Invasive Methicillin-Resistant Staphylococcus aureus Infection — 9 U.S. States, 2006–2013
- Lee Harrison
- Poster 1378. Evaluation of the in vitro activity of meropenem-vaborbactam against carbapenem-resistant Enterobacteriaceae, including isolates resistant to ceftazidime-avibactam
- Will Wilson,Ryan Shields, Neil Clancy, Hong Nguyen
- Poster 1528. A real world perspective on treatment of CRE UTIs with oral agents
- Ahmed Babiker, Lloyd Clarke, Ryan Shields
- Poster 1529. Suprapubic Catheter Placement Improves Antimicrobial Stewardship in a Veterans Affairs Long-term Care Facility
- Deanna Buehrle, Neil Clancy, Brooke Decker
- Poster 1571. Cost-effectiveness analysis of duration of valganciclovir prophylaxis among CMV serology mismatched (donor+/recipient-) lung transplant recipients
- Neil Clancy, Hong Nguyen
Saturday 10/6/18
9:00 AM Room S 156
- Oral Abstract: A Random Forest Prediction Model Accurately Identifies Periods at Increased Risk for Positive Legionella Cultures in a Hospital Water Distribution System
- Brooke Decker, Neil Clancy
915 AM Room S 157
- Oral Abstract: The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia
- Lee Harrison
12:30 PM Poster Hall
- Poster 1796. Inappropriate Aztreonam Usage Identified as an Opportunity to Reduce Pharmaceutical Expenditures
- Mohamed Yassin, Brandon Smith
- Poster 1880. Does the Label Matter: Initial Use of Newly Approved Antimicrobial Agents in Community Hospitals Without Robust Antimicrobial Stewardship Programs
- Tina Khadem, Ryan Bariola
- Poster 1938. Sustained Reduction in 30 day Readmission Rates after Implementation of an OPAT Program in an Academic Medical Center
- Katie Sheridan, Meg Anderson, Josh Wingfield, Lauren McKibben
- Poster 1942. Expansion of Outpatient Parenteral Therapy Program with Addition of Advanced Practice Providers Can Lead to Reduced Readmission Rates
- Katie Sheridan, Meg Anderson, Josh Wingfield,
- Poster 2438. Ceftolozane/tazobactam (C/T) against multidrug-resistant Pseudomonas aeruginosa (MDR-Pa) infections: Clinical efficacy, and baseline and emergent resistance
- Ryan Shields, Ghady Haidar, Brian Potoski, Yohei Doi, Rachel Marini, Hong Nguyen, Neil Clancy
- Poster 2421 Tedizolid is well-tolerated among patients receiving prolonged treatment courses
- Rachel Marini, Lloyd Clarke, Ryan Shields
- Poster 2420: A real-world perspective on the efficacy of fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infections
- Ahmed Babiker, Lloyd Clarke, Ryan Shields
- Poster 2403. Comparison of Daptomycin Combination Therapy with Ceftaroline or Oxacillin Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Causing Persistent Bacteremia
- Ellen Kline, Ryan Shields
- Poster 2065. Whole Genome Sequencing for Antimicrobial Resistance Prediction in MRSA and VRE: A Real World Application
- Ahmad Babiker, Mustapha Mustaph, Yohei Doi, Lee Harrison
- Poster 2033. Incorporating T2Candida testing into rational antifungal (AF) management: A successful pilot study of diagnostic stewardship (DS) directed toward specific intensive care unit (ICU) patients (pts) at-risk for sepsis due to invasive candidiasis (IC)
- Ryan Shields, Neil Clancy, Rachel Marini, Bonnie Falcione, Bill Pasculle, Hong Nguyen
- Poster 2161. Pilot Implementation of a Nationwide Automated Multidrug-Resistant Organism Tracking and Alert System in Veterans Affairs
- Brooke Decker
4:00 PM N Hall D
- Oral Abstract 74389. Preemptive therapy (PET) versus prophylaxis for prevention of cytomegalovirus (CMV) disease in high-risk donor seropositive/recipient seronegative (D+R-) liver transplant recipients (LTR): A NIH-sponsored, randomized, controlled, multi center trial
- Nina Singh, Fernanda Silveira